Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives.

@article{Mazires2013LungCT,
  title={Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives.},
  author={J. Mazi{\`e}res and S. Peters and B. Lepage and A. Cortot and F. Barlesi and M. Beau-Faller and B. Besse and H. Blons and A. Mansuet‐Lupo and T. Urban and D. Moro-Sibilot and {\'E}. Dansin and C. Chouaid and M. Wislez and J. Diebold and E. Felip and I. Rouquette and J. Milia and O. Gautschi},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2013},
  volume={31 16},
  pages={
          1997-2003
        }
}
  • J. Mazières, S. Peters, +16 authors O. Gautschi
  • Published 2013
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • PURPOSE HER2 mutations are identified in approximately 2%of non-small-cell lung cancers (NSCLC). There are few data available that describe the clinical course of patients with HER2-mutated NSCLC. PATIENTS AND METHODS We retrospectively identified 65 NSCLC, diagnosed with a HER2 in-frame insertion in exon 20. We collected clinicopathologic characteristics, patients' outcomes, and treatments. RESULTS HER2 mutation was identified in 65 (1.7%) of 3,800 patients tested and was almost an… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The purpose of this study is to investigate the control of disease in pretreated patients with advanced non small cell lung cancer (NSCLC) harbouring HER2 exon 20 mutations as well as… Expand
    ConditionsNSCLC
    InterventionDrug

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 27 REFERENCES
    Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas
    • 267
    • PDF
    Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.
    • 118